Literature DB >> 27208321

Long-term Variability in Glycemic Control Is Associated With White Matter Hyperintensities in APOE4 Genotype Carriers With Type 2 Diabetes.

Abigail Livny1, Ramit Ravona-Springer2, Anthony Heymann3, Rachel Priess4, Tammar Kushnir5, Galia Tsarfaty5, Leeron Rabinov6, Reut Moran6, Hadass Hoffman7, Itzik Cooper8, Lior Greenbaum7, Jeremy Silverman9, Mary Sano10, Sterling C Johnson11, Barbara B Bendlin11, Michal Schnaider Beeri8.   

Abstract

OBJECTIVE: We assessed whether the apolipoprotein ε4 (APOE4) genotype affects the relationship of variability in long-term glycemic control (measured by HbA1c SD of multiple measurements) with white matter hyperintensities (WMHs) in elderly patients with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: WMH volume was generated from structural T1 and fluid-attenuated inversion recovery MRI in each subject. The analysis included 124 subjects; 27 (21.8%) had one or more APOE4 alleles.
RESULTS: HbA1c variability was associated with significantly higher WMH in APOE4 carriers (r = 0.47, P = 0.03), controlling for age, sex, mean HbA1c, number of follow-up years, and a composite of cardiovascular risk factors, but not in noncarriers (r = -0.04, P = 0.71; P for interaction = 0.050).
CONCLUSIONS: The results suggest that the APOE4 genotype affects the relationship of long-term glycemic control with WMH load so that APOE4 carriers may be more vulnerable to the insults of poor control.
© 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27208321      PMCID: PMC5317241          DOI: 10.2337/dc15-2331

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  17 in total

1.  Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia.

Authors:  N Hirono; M Yasuda; S Tanimukai; H Kitagaki; E Mori
Journal:  Stroke       Date:  2000-06       Impact factor: 7.914

2.  The Israel Diabetes and Cognitive Decline (IDCD) study: Design and baseline characteristics.

Authors:  Michal Schnaider Beeri; Ramit Ravona-Springer; Erin Moshier; James Schmeidler; James Godbold; Tomas Karpati; Derek Leroith; Keren Koifman; Efrat Kravitz; Rachel Price; Hadas Hoffman; Jeremy M Silverman; Anthony Heymann
Journal:  Alzheimers Dement       Date:  2014-08-20       Impact factor: 21.566

3.  An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis.

Authors:  Paul Schmidt; Christian Gaser; Milan Arsic; Dorothea Buck; Annette Förschler; Achim Berthele; Muna Hoshi; Rüdiger Ilg; Volker J Schmid; Claus Zimmer; Bernhard Hemmer; Mark Mühlau
Journal:  Neuroimage       Date:  2011-11-18       Impact factor: 6.556

4.  Effects of vascular risk factors and APOE ε4 on white matter integrity and cognitive decline.

Authors:  Rui Wang; Laura Fratiglioni; Erika J Laukka; Martin Lövdén; Grégoria Kalpouzos; Lina Keller; Caroline Graff; Alireza Salami; Lars Bäckman; Chengxuan Qiu
Journal:  Neurology       Date:  2015-02-11       Impact factor: 9.910

5.  Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes.

Authors:  Jeroen de Bresser; Audrey M Tiehuis; Esther van den Berg; Yael D Reijmer; Cynthia Jongen; L Jaap Kappelle; Willem P Mali; Max A Viergever; Geert Jan Biessels
Journal:  Diabetes Care       Date:  2010-03-18       Impact factor: 19.112

6.  Diabetes increases brain damage caused by severe hypoglycemia.

Authors:  Adam J Bree; Erwin C Puente; Dorit Daphna-Iken; Simon J Fisher
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-12       Impact factor: 4.310

7.  HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2.

Authors:  A Sugawara; K Kawai; S Motohashi; K Saito; S Kodama; Y Yachi; R Hirasawa; H Shimano; K Yamazaki; H Sone
Journal:  Diabetologia       Date:  2012-05-12       Impact factor: 10.122

8.  Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus.

Authors:  C Jongen; J van der Grond; L J Kappelle; G J Biessels; M A Viergever; J P W Pluim
Journal:  Diabetologia       Date:  2007-05-11       Impact factor: 10.122

9.  Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.

Authors:  Giuseppe Penno; Anna Solini; Giacomo Zoppini; Emanuela Orsi; Cecilia Fondelli; Gianpaolo Zerbini; Susanna Morano; Franco Cavalot; Olga Lamacchia; Roberto Trevisan; Monica Vedovato; Giuseppe Pugliese
Journal:  Cardiovasc Diabetol       Date:  2013-07-05       Impact factor: 9.951

Review 10.  Neurocognitive changes and their neural correlates in patients with type 2 diabetes mellitus.

Authors:  Junghyun H Lee; Yera Choi; Chansoo Jun; Young Sun Hong; Han Byul Cho; Jieun E Kim; In Kyoon Lyoo
Journal:  Endocrinol Metab (Seoul)       Date:  2014-06
View more
  9 in total

1.  HIV disease and diabetes interact to affect brain white matter hyperintensities and cognition.

Authors:  Minjie Wu; Omalara Fatukasi; Shaolin Yang; Jeffery Alger; Peter B Barker; Hoby Hetherington; Tae Kim; Andrew Levine; Eileen Martin; Cynthia A Munro; Todd Parrish; Ann Ragin; Ned Sacktor; Eric Seaberg; James T Becker
Journal:  AIDS       Date:  2018-08-24       Impact factor: 4.177

2.  Glycemic Variability and Brain Glucose Levels in Type 1 Diabetes.

Authors:  Janice J Hwang; Lihong Jiang; Elizabeth Sanchez Rangel; Xiaoning Fan; Yuyan Ding; Wai Lam; Jessica Leventhal; Feng Dai; Douglas L Rothman; Graeme F Mason; Robert S Sherwin
Journal:  Diabetes       Date:  2018-10-16       Impact factor: 9.461

3.  Distinct Dimensions of Depression Are Associated With Different Brain-Related Biomarkers.

Authors:  Laili Soleimani; Michal Schnaider Beeri; Anthony Heymann; Abigail Livny; Orit Lesman-Segev; Hung-Mo Lin; Yuxia Ouyang; Ramit Ravona-Springer
Journal:  Diabetes Care       Date:  2022-05-01       Impact factor: 17.152

4.  Association of Life's Simple 7 with incident dementia and its modification by the apolipoprotein E genotype.

Authors:  Jing Guo; Adam M Brickman; Jennifer J Manly; Christiane Reitz; Nicole Schupf; Richard P Mayeux; Yian Gu
Journal:  Alzheimers Dement       Date:  2021-05-02       Impact factor: 21.566

5.  Association of Variability in Body Mass Index and Metabolic Health With Cardiometabolic Disease Risk.

Authors:  Todd R Sponholtz; Edwin R van den Heuvel; Vanessa Xanthakis; Ramachandran S Vasan
Journal:  J Am Heart Assoc       Date:  2019-04-02       Impact factor: 5.501

6.  Metabolic syndrome alters relationships between cardiometabolic variables, cognition and white matter hyperintensity load.

Authors:  E Alkan; T P Taporoski; A Sterr; M von Schantz; H Vallada; J E Krieger; A C Pereira; R Alvim; A R V R Horimoto; S Pompéia; A B Negrão; S L H Evans
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

7.  Alzheimer's Disease Polygenic Risk Score Is Not Associated With Cognitive Decline Among Older Adults With Type 2 Diabetes.

Authors:  Sigalit B Manzali; Eric Yu; Ramit Ravona-Springer; Abigail Livny; Sapir Golan; Yuxia Ouyang; Orit Lesman-Segev; Lang Liu; Ithamar Ganmore; Anna Alkelai; Ziv Gan-Or; Hung-Mo Lin; Anthony Heymann; Michal Schnaider Beeri; Lior Greenbaum
Journal:  Front Aging Neurosci       Date:  2022-08-30       Impact factor: 5.702

8.  Postprandial Hyperglycemia Is Associated With White Matter Hyperintensity and Brain Atrophy in Older Patients With Type 2 Diabetes Mellitus.

Authors:  Noriko Ogama; Takashi Sakurai; Shuji Kawashima; Takahisa Tanikawa; Haruhiko Tokuda; Shosuke Satake; Hisayuki Miura; Atsuya Shimizu; Manabu Kokubo; Shumpei Niida; Kenji Toba; Hiroyuki Umegaki; Masafumi Kuzuya
Journal:  Front Aging Neurosci       Date:  2018-09-12       Impact factor: 5.750

Review 9.  Perspectives of glycemic variability in diabetic neuropathy: a comprehensive review.

Authors:  Xiaochun Zhang; Xue Yang; Bao Sun; Chunsheng Zhu
Journal:  Commun Biol       Date:  2021-12-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.